Health Economics

The Health Economics team at the Centre for Medicine Use and Safety (CMUS) is a multidisciplinary team that brings together health economists, epidemiologists and pharmacists. We work across a number of therapeutic streams within Faculty of Pharmacy and Pharmaceutical Sciences, and collaborate with government agencies, industry, and consumer representatives to optimise healthcare in Australia.

Our work involves the use of state-of-the-art epidemiological and health economic models to evaluate the real-world impact of ill-health, as well as the potential benefits of contemporary genetic screening, novel pharmacological treatments, and remuneration systems for pharmacy services.

To date, our work has benefited healthcare worldwide through enhancing evidence-based practice, improving clinical guidelines, and driving policy change. Health economic decision models and new health metrics designed through our research program have provided evidence on the benefits and costs of health interventions where little or no evidence previously existed. Substantiation of cost-effectiveness has enabled key decision makers (both national governments and private payers) to enact effective healthcare policies, improving healthcare and promoting equity.

Research activities: What we do

  • Economic evaluation alongside clinical trials, cohort and case control studies.
  • Decision health economic modelling
  • Budget Impact Analysis and Return on Investment
  • Distributional cost-effectiveness analysis (DCEA)
  • Epidemiological modelling
  • Economic evaluation of clinical pharmacy services
  • Health technology assessment (HTA), systematic reviews and meta-analyses
  • Quantifying disease burden through productivity measurement
  • Data linkage and analysis of administrative data such as the Pharmaceutical Benefit Scheme (PBS) and Medicare Benefits Schedule (MBS)
  • Health Services Research

Key therapeutic focus of our health economics research

  • Cardiovascular Disease and Diabetes
  • Epilepsy
  • Genomics
  • Oncology
  • Neurodegenerative Diseases
  • Geriatrics
  • Vaccines
  • Maternal Health
  • Musculoskeletal disorders

Principal investigator

Post-doctoral researchers 

PhD students 

  • Dina Abushanab
  • Yeji Baek